-

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Via Transportation, Inc. (VIA) Shareholders to Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Via Transportation, Inc. (“Via” or the “Company”) (NYSE: VIA) common stock pursuant and/or traceable to the Company’s September 2025 initial public offering (the “IPO”). Via investors have until August 10, 2026 to file a lead plaintiff motion.

IF YOU SUFFERED A LOSS ON YOUR VIA TRANSPORTATION, INC. (VIA) INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS

What Happened?

On September 15, 2025, Via conducted its IPO, selling 10,714,285 shares of common stock at $46.00 per share.

On November 13, 2025, Via released its third quarter 2025 financial results and disclosed that the Annual Run-Rate Revenue (“ARR”) per customer declined for the first time in eight quarters due to “normal seasonality patterns of . . . existing contracts.”

On this news, Via’s stock price fell $7.36, or 14.6%, to close at $43.14 per share on November 13, 2025, thereby injuring investors.

Then, on February 27, 2026, Via released its fourth quarter and full year 2025 financial results, disclosing that the Company was “facing some headwinds . . . in Germany.” Specifically, “the regulatory environment in Europe, [was] just proving to be a longer process.”

On this news, Via’s stock price fell $1.40, or 7.5%, to close at $17.18 per share on February 27, 2026.

Then, on May 12, 2026, Via released its first quarter 2026 financial results and stated that the Company “continue[s] to face headwinds in Germany as [its] customers continue to navigate a sustained constrained budgetary environment.”

On this news, Via’s stock price fell $2.81, or 16.6%, to close at $14.12 per share on May 12, 2026, nearly 70% below the IPO price.

What Is the Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company’s ARR per customer was declining and that existing regulatory issues would hinder its “land and expand” strategy in Germany; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Via common stock pursuant and/or traceable to the IPO, you may move the Court no later than August 10, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us to Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Charles Linehan, Esq.
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, California 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Glancy Prongay Wolke & Rotter LLP

NYSE:VIA

Release Versions

Contacts

Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

More News From Glancy Prongay Wolke & Rotter LLP

Securities Fraud Class Action Filed Against D-Wave Quantum, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired the Company's securities between February 26, 2026 and August 25, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced the filing. The D-Wave Quantum, Inc. case, Fessler v. D-Wave Quantum, Inc. et al., was filed on October 15, 2026 in the U.S. District C...

Deadline Alert: Bank Of America Corporation Investors Have Until December 15, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

LOS ANGELES--(BUSINESS WIRE)--Investors in Bank Of America Corporation ("Bank of America" or the "Company") (NYSE: BAC) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Bank Of America Corporation securities between August 1, 2025 and October 13, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline....

Lost Money on Moderna, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 23.07% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Moderna, Inc. ("Moderna" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Moderna, Inc. (NASDAQ: MRNA) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Moderna, Inc.Investors who lost money on Moderna, Inc. securit...
Back to Newsroom